Malignant pleural effusion (MPE) is an exudative effusion with malignant cells. MPE is a
common symptom and accompanying manifestation of metastatic disease. It affects up to …

Background Thoracentesis and thoracoscopy are used to diagnose malignant pleural
effusions (MPE). Data on how sensitivity varies with tumour type is limited. Methods …

The COVID-19 pandemic, characterised by a fast and global spread during the first months
of 2020, has prompted the development of a structured set of recommendations for cancer …

Importance Malignant pleural effusion (MPE) is challenging to manage. Talc pleurodesis is a
common and effective treatment. There are no reliable data, however, regarding the optimal …

A total of 21 659 pleural aspirations or drain insertions were conducted in England in
2019/2020 with a combined cost of£ 13.4 million. 1 There are now a variety of different …

Symptomatic malignant pleural effusion is a common clinical problem. This condition is
associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies …

Chylothorax, the accumulation of chyle in the pleural space, is usually caused by the
disruption of the thoracic duct or its tributaries. Etiologies are broadly divided into traumatic …

Most children with tumors will require one or more surgical interventions as part of the care
and treatment, including making a diagnosis, obtaining adequate venous access …

Background Pleurodesis is done as an in-patient procedure to control symptomatic recurrent
malignant pleural effusion (MPE) and has a success rate of 75–80%. Thoracic …

Pleural effusion is a common respiratory disease worldwide; however, rapid and accurate
diagnoses of tuberculosis pleural effusion (TPE) and malignancy pleural effusion (MPE) …